The year 2020 was welcomed and characterized with a report of pneumonia of unknown etiology, which occurred primarily in Wuhan City of Hubei Province of China. Between 31 December 2019 and 3 January 2020, a total of 44 cases in human was reported to the World Health Organization (WHO) by the Chinese Health Authorities[1]. By 3 February 2020, a total of 17391 cases have been confirmed globally with 2838 new cases (China: 17238; 2831 new cases and 361 deaths; Outside China: 153 with 7 new cases and 1 death from 23 countries)[1]. Wuhan City of Hubei Province has accounted for approximately 64.8％ of all cases from China. Globally, the risk of infection and spread remains high. The pathogen causing the infection has been classified as 2019 novel coronavirus (2019-nCoV). Due to a surge in numbers of cases from the third week of January 2020, and after intense consultations and deliberations by the Intational Health Regulations (2005) Emergency Committee, the WHO, on 30 January 2020 declared the outbreak of 2019-nCoV a Public Health Emergency of Intational Conc (PHEIC)[2,3]. Since the date of this declaration, global attention has been focused on 2019-nCoV[4,5].